Testavan listed
TESTOSTERONE replacement therapy (TRT), Testavan, has been listed on the Pharmaceutical Benefits Scheme (PBS) for the treatment of hypogonadal in men who meet reimbursement criteria.
The transdermal gel enhances bioavailability of testosterone through the skin.